Reconsideration of the clinical management of hepatic hemangioma

Table 2 Efficacy of transcatheter arterial embolization or transarterial chemoembolization for hepatic hemangioma

Ref.	Years	Type	Treatment	Efficacy
Özgür and Sindel[24]	2021	Retrospective study	TAE vs TACE	TACE is superior to TAE in reducing hepatic hemangioma volume and pain
Yuan et al[25]	2022	Retrospective study	TACE	At follow-up ≥ 5 years, 86.5% of hepatic hemangiomas had a maximum postoperative diameter reduction of more than 50%
Kacała et al[26]	2023	Retrospective study	TACE	77.5% of the patients with hepatic hemangioma embolism rate more than 75%
Kacała et al[27]	2024	Retrospective study	TACE	The volume of hepatic hemangioma was reduced by more than 50% in 80.6% of patients
Zhao D et al[28]	2024	Multicenter retrospective study	TACE	The volume of tumor was reduced by more than 50% in 80.7% of hepatic hemangiomas

TAE: Transarterial embolization; TACE: Transarterial chemoembolization.